Position in EXEL
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$4,610,503
-$1,545,245 QoQ
Shares Held
107,496
-23.5% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NISA INVESTMENT ADVISORS, LLC holds $80,190,121 across 241 Biotechnology names. EXEL ranks #3 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,183 | $25,981,036 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,771 | $15,275,865 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
107,496 | $4,610,503 | |
| 4 | TECH |
BIO-TECHNE Corp
|
72,813 | $3,805,207 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,357 | $3,095,950 | |
| 6 | INCY |
Incyte Corp
|
31,835 | $2,996,310 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
81,912 | $2,268,962 | |
| 8 | INSM |
INSMED Inc
|
13,447 | $2,198,853 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,610,503 | 107,496 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,155,748 | 140,446 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $732,083 | 17,726 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $4,590,314 | 104,136 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,967,940 | 107,474 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,078,386 | 62,414 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $126,895 | 4,890 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $112,911 | 5,025 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,012,772 | 42,679 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $195,278 | 8,140 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $94,829 | 4,340 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $82,937 | 4,340 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $84,239 | 4,340 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $506,238 | 31,561 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $43,120 | 2,750 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $231,518 | 11,120 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $252,090 | 11,120 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $271,256 | 14,839 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $387,242 | 18,318 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $411,280 | 22,573 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $509,924 | 22,573 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $453,040 | 22,573 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $406,163 | 16,612 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $525,651 | 22,142 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $223,601 | 12,985 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||